Relmada Appoints Bipin Dalmia As Chief Business Officer
Relmada Therapeutics announced the appointment of Bipin Dalmia, PhD, as Chief Business Officer to lead strategy and business development for its NDV-01 therapy. This leadership change supports the company's growth and commercialization focus.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day